Context Therapeutics (CNTX) Other Non Operating Income (2024 - 2026)

Context Therapeutics has reported Other Non Operating Income for 3 years, with the latest figure at $143088.0 in Q1 2026.

• Quarterly Other Non Operating Income rose 2256.56% year-over-year to $143088.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350194.0 (up 3167.57% YoY) and the FY2025 annual result came in at $200471.0, up 14138.59% from the prior year.
• Other Non Operating Income climbed to $143088.0 in Q1 2026 per CNTX's latest filing, from $96555.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $143088.0 in Q1 2026 and troughed at -$6635.0 in Q1 2025.
• A 3-year average of $38014.6 and a median of $3478.0 in 2024 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 3978.76% in 2025, down 297.88% in 2025.
• Over 3 years, Other Non Operating Income stood at $3478.0 in 2024, then soared by 2676.16% to $96555.0 in 2025, then soared by 48.19% to $143088.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $143088.0, $96555.0, and $83471.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.